Pharmacological considerations during pregnancy

Current Opinion in Anaesthesiology

Volumn 14, Issue 3, 2001, Pages 311-316

  Cox, P Boris W ^a   Marcus, Marko A E ^a   Bos, Herman ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANESTHETIC AGENT; ANTIHYPERTENSIVE AGENT; BUPIVACAINE; KETAMINE; LEVOBUPIVACAINE; LIDOCAINE; MAGNESIUM SULFATE; PROPOFOL; ROPIVACAINE;

ANTIHYPERTENSIVE THERAPY; DELIVERY; FEMALE; GENERAL ANESTHESIA; HUMAN; LABOR; OBSTETRIC ANESTHESIA; PREGNANCY; PRIORITY JOURNAL; REGIONAL ANESTHESIA; REVIEW;

EID: 0034988424     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200106000-00005     Document Type: Review

References (54)

1. Maternal levels of propofol at caesarean section
2. Disposition of propofol infusions for caesarean section
3. The effect of propofol on isolated human pregnant uterine muscle
4. Intravenous propofol vs thiamylalisoflurane for caesarean section, comparitive maternal and neonatal effects
5. Subhypnotic dose of propofol for the prevention of nausea and vomiting during spinal anaesthesia for caesarean section
6. A randomised comparison between midazolam and thiopental for elective caesarean section anesthesia: III. Placental transfer and elimination in neonates
7. Plasma catecholamines and neonatal condition after induction of anesthesia with propofol or thiopentone at caesarean section
8. Propofol for induction of anaesthesia at caesarean section: A comparison with thiopentone/enflurane
9. Thiopentone, thiopentone/ketamine, and ketamine for induction of anesthesia in caesarean section
10. Effect of thiopental on vascular resistance in human placental chorionic arteries under conditions of hyper-, norm- and hypoxia
11. Nonbarbiturate intravenous anesthetics
12. Influence of two different anaesthetic agents on the newborn and the correlation between foetal oxygenation and induction-delivery time in elective caesarean section
13. Anesthesia for obstetrics
14. Sevoflurane inhalation induction for emergency caesarean section in a parturient with no intravenous access
15. Uptake of halothane and isoflurane by mother and baby during caesarean section
16. Isoflurane or halothane for caesarean section: Comparative maternal and neonatal effects
17. Comparison of the maternal and neonatal effects of halothane, enflurane and isoflurane for caesarean delivery
18. Use of sevoflurane during elective caesarean birth: A comparison with isoflurane and spinal anesthesia
19. Comparison of sevoflurane with isoflurane anesthesia for use in elective caesarean section
20. Rapacurorium for modified rapid sequence induction in elective caesarean section: Neuromuscular blocking effects and safety compared with succinylcholine and placental transfer
21. Hemodynamic, pulmonary vascular, and myocardial abnormalities secondary to pharmacologic constriction of the fetal ductus arteriosus. A possible mechanism for persistent pulmonary hypertension and transient tricuspic incompetence in new-born infants
22. Diclofenac in the treatment of pain after caesarean delivery. An opioid-saving strategy
23. Post-operative analgesia with morphine versus morphine and paracetamol. A double-blind clinically controlled study with a placebo
24. Rectal paracetamol has a significant morphine-sparing effect after hysterectomy
25. The morphine sparing effect of propacetamol in orthopedic postoperative pain
26. Naproxen improves post caesarean analgesia after spinal morfine
27. Alfentanyl given immediately before the induction of anesthesia for elective caesarean delivery
28. Acute opioid tolerance. Intraoperative remifentanyl increases postoperative pain and morphine requirement
29. Is blood pressure the best parameter to evaluate volume preload on obstetric anesthesia?
30. Human perinatal pharmacology: Recent controversies
31. Lidocaine hydrocarbonate and lidocaine hydrochloride for caesarean section: Transplacental passage and neonatal effects
32. Effects of fetal pH on local anesthetic transfer across the human placenta
33. Bupivacaine transfer across the human term placenta
34. Disposition of bupivacaine and its metabolites in the maternal, placental and fetal compartments in rats
35. Ropivacaine
36. Comparison of 0.125% bupivacaine and 0.2% ropivacaine in obstetric analgesia
37. Analgesia for labour pain with ropivacaine
38. Intrathecal anesthesia: Ropivacaine versus bupivacaine
39. Intrathecal ropivacaine for ambulatory surgery
40. Ropivacaine: An update of its use in regional anaesthesia
41. A comparison of epidural analgesia with 0.125% ropivacaine with fentanyl versus 0.125% bupivacaine with fentanyl during labour
42. Ropivacaine
43. The role of new anesthetic agents
44. Epidural ropivacaine for the initiation of labor epidural analgesia: A dose finding study
45. A double-blind comparison of 0.125% ropivacaine with sufentanyl and 0.125% bupivacaine with sufentanyl for epidural labor analgesia
46. Levobupivacaine: A review of its pharmacology and use as a local anaesthetic
47. Levobupivacaine for epidural analgesia in labour; the sparings effect of epidural fentanyl
48. Clinical effects and maternal and fetal plasma of 0.5% epidural levobupivacaine versus bupivacaine for caesarean delivery
49. Membrane, intracellular and plasma magnesium and calcium concentrations in preeclampsia
50. Is the prophylactic administration of magnesium sulphate in women with pre-eclampsia indicated prior to labour?
51. Magnesium prevents seizure-induced reduction in excitatory amino acid receptor (kainite and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) binding in pregnant rat brain
52. Magnesium sulfate in eclampsia and pre-eclampsia: Pharmacokinetic principles
53. Unexpected hyperkalemia following succinylcholine administration in prolonged immobilized parturients treated with magnesium and ritodrine
54. Treatment of intrauterine growth retardation with magnesium sulfate